Past Meetings

The GCIG Spring 2019 meeting was held May 29-30, 2019 in Chicago, IL.

Invitation Letter

Schedule - v May 23, 2019

Satellite Sessions Schedule - v May 23, 2019

Photos

Nominations/Meetings Working Group

• Agenda

Education Working Group/GREAT

• Agenda

Communication Working Group

• Agenda

Harmonization Ops/Joint Ops

• Agenda
• Financial Toxicity Slides

Harmonization Stats Committee

• Agenda

Meta-Analysis Working Group

• Agenda
• Adjuvant Treatment of Endometrial Cancer - Mileshkin

Phase II Committee

• Agenda
• NRG-GY005
• ENGOT-OV24-NSGO-AVANOVA Part 2
• ENGOT-OV42 NSGO/AVATAR
• ATOMICC
• Cx7/NSGO/MaRuC
• ENGOT-OV30/NSGO/UMBRELLA

Rare Tumours Committee

• Agenda
• ALIENOR
• ITICC
• NRG-GY-019
• ROCSAN

Endometrial Cancer Committee

• Agenda
• ECCo
• SIENDO
• ECLAT
• TOTEM
• FANDANGO
• SAVE
• AtTEnd
• NRG/GOG Uterine Corpus trials
• Challenging Debate
• Minutes

Ovarian Cancer Committee

• Agenda
• ICON 8B, ICON 9
• FIRST
• OREO, ATALANTE
• ENGOT-ov41/ANITA
• UMBRELLA
• ENGOT-ov43, ENGOT-ov50
• ENGOT-ov31, ENGOT-ov34, ENGOT-ov46
• NiCCC
• VIP
• JGOG 3020
• LANCE
• iPrime-2
• NRG
• OCCC
• The EPOCH Study

Symptom Benefit Committee

• Agenda
• ATALANTE
• SBS2
• EmQuest
• EoL Pilot
• Expression VI
• Expression IX
• Minutes

Cervix Cancer Committee

• Agenda
• AGOG
• BGOG
• CEEGOG
• GEICO
• GOG-F
• KGOG
• NCRI
• PMHC

Translational Research Committee

• Agenda
• JGOG

General Assembly

• Agenda
• Cervix Cancer Committee Report
• Harmonization Committee/Working Group Report
• Translational Research Committee Report
• Endometrial Cancer Committee Minutes
• Rare Tumour Committee Report
• Rare Tumour Working Group Minutes
• Symptom Benefit Committee Minutes
• Meta-Analysis Working Group Report
• CCRN Working Group Report

The 2018 GCIG Autumn meeting will be held October 17-18, 2018 in Munich, Germany at Klinikum der Universitat Munchen. Location: Campus Innenstadt, Maistr. 11, 80337 Munchen.

• Invitation Letter
• Schedule
• Education Symposium Program
• Imaging-Pathology Brainstorming Program
• Satellite Sessions Schedule
• Harmonization Stats Agenda
• Harmonization Ops Committee Agenda
• Ovarian Cancer Committee Agenda
• Endometrial Cancer Committee Agenda
• Cervix Cancer Committee Agenda
• Rare Tumours Committee Agenda
• Education WG/GREAT Agenda
• Meta-Analysis WG Agenda
• Phase II Committee Agenda
• Translational Research Committee Agenda
• Symptom Benefit Committee Agenda
• CCRN Agenda
• General Assembly Agenda

GCIG - October 17-18, 2018

GCIG Education Symposium - by invitation - October 17, 2018

GCIG Imaging-Pathology Brainstorming - limited registration - October 17, 2018

Imaging-Pathology Brainstorming - Munich 2018

• Program
• McNeish slides
• Ricke slides
• Gaffney slides
• Berek slides
• Bryson slides
• Rahimi slides
• Millan slides

Educational Symposium - Munich 2018

Ovarian Cancer Committee

• Agenda
• GINECO SOLO-2
• NRG
• ICON8/ICON8B
• NSGO UMBRELLA
• AVANOVA Part 3
• ATALANTE
• MITO 23
• ICON9
• NSGO/ENGOT OV41/ANITA
• ATHENA
• MITO 25
• NSGO/ENGOT OV42/BAN-ROC
• KGOG 3045/AMBITION
• DGOG OVHIPEC 2
• GINECO PAOLA-1
• GINECO ALIENOR

Endometrial Cancer Committee

• Agenda
• MITO (ECCO)
• NCRI (STATEC)
• AGO (ECLAT)
• NSGO (EN2)
• DGOG (Portec-4a)
• COGI (SAVE)
• MITO (AEC)
• NSGO (EN1-Fandango)
• NSGO (EN3-PALEO)
• MaNGO (AtTEnd)

Cervix Cancer Committee

• Agenda
• Cx1 Randomized Phase II (BGOG)
• CONTESSA/NEOCON-F (CCTG)
• SHAPE (CCTG)
• GROINSS-V II (DGOG)
• SENTICOL III (GINECO)
• NRG/GOG-F
• GOG263, TACO (KGOG)
• INTERLACE (NCRI)
• EORTC 55994 (EORTC GCG)
• MaRuC (NSGO)
• AGOG18-005
• BEATcc (GEICO)
• Empower Cervical 1 (GEICO)

Rare Tumours Committee

• Agenda
• EORTC High Grade Uterine Sarcoma
• NiCC (Clear Cell)
• ROSCAN
• ITICC
• MOCCA
• ATARI
• GCIG/ESGO Guidelines

Phase II Committee

• Agenda
• NRG GY019
• NRG GY005
• PMHC NEO, eVOLVE
• NSGO
• GTAC GEICO
• GTAC NSGO
• GTAC PMHC

Symptom Benefit Committee

• Agenda
• QoL Publications
• QoL Ongoing Trials
• Resilience in Cancer Treatment
• PRO CTCAEs

General Assembly

• Agenda
• Webmaster Report
• Cervix Cancer Committee Report
• Harmonization Ops Committee Report
• Translational Research Committee Report
• Rare Tumour Committee Report
• Meta-Analysis Working Group Report

Chicago 2018 will be held May 30-31, 2018 at the Palmer House Hilton. Location: 17 E Monroe St, Chicago, IL 60603

• Invitation Letter
• Schedule - v May 29, 2018
• Satellites Sessions Schedule - v May 21, 2018
• Nominations/Meeting Working Group Agenda
• QA Working Group Agenda
• Meta-Analysis Working Group Agenda
• Education Working Group Agenda
• Ovarian Cancer Committee Agenda
• Cervix Cancer Committee Agenda
• Symptom Benefit Committee Agenda
• Harmonization Operations Agenda
• Harmonization Stats Agenda
• Phase II Committee Agenda
• CCRN Agenda
• Endometrial Cancer Committee Agenda
• Rare Tumours Committee Agenda
• Translational Research Committee Agenda
• General Assembly Agenda

General Assembly

• General Assembly Agenda
• CCRN Report
• Endometrial Cancer Committee Report
• Ovarian Cancer Committee Report
• Harmonization Ops Report
• Harmonization Stats Report
• Translational Research Committee Report
• Rare Tumours Committee Report
• Symptom Benefit Committee Report
• Phase II Committee Report
• Meta-Analysis Working Group Report
• QA Working Group Report

Nominations/Meeting Working Group

• Nominations/Meeting Working Group Agenda

QA Working Group

• QA Working Group Agenda
• QA Working Group Minutes

Meta-Analysis Working Group

• Meta-Analysis Working Group Agenda

Education Working Group

• Education Working Group Agenda

Ovarian Cancer Committee

• Ovarian Cancer Committee Agenda
• Ovarian Cancer Committee Slides

Cervix Cancer Committee

• Cervix Cancer Committee Agenda
• EORTC
• ANZGOG OUTBACK
• BGOG
• CONTESSA / NEOCON-F
• CCTG SHAPE
• GROINSS-V II
• SENTICOL III
• NRG 278, 3009, GY006, 279, 3016
• GOG 263
• TACO
• INTERLACE
• EXCISE
• AGOG

Symptom Benefit Committee

• Symptom Benefit Committee Agenda

Harmonization Committee: Operations/Stats

• Harmonization Operations Agenda
• Harmonization Stats Agenda

Phase II Committee

• Phase II Committee Agenda
• Phase II Committee Slides

CCRN

• CCRN Agenda

Endometrial Cancer Committee

• Endometrial Cancer Committee Agenda
• Endometrial Cancer Committee Slides

Rare Tumours Committee

• Rare Tumours Committee Agenda

Translational Research Committee

• Translational Research Committee Agenda

General Assembly

• General Assembly Agenda
• Symptom Benefit Committee Report
• Quality Assurance Brainstorming Report
• Translational Research Committee Report
• Harmonization Stats Committee Report
• Rare Tumours Committee Report
• Education Working Group Report

Cervix Cancer Research Network

• Agenda

Harmonization Committee: Operations/Stats

• Agenda

Nominations & Meeting Working Group

Symptom Benefit Committee

• Agenda
• End of Life Care - NGSO

Cervix Cancer Committee

• Agenda
• AGOG14001
• BGOG Cx1
• CCTG SHAPE
• G-GOC ConCerv LACC
• GINECO SENTICOLIII
• GOG-F
• Hypofractionation
• NCRI Interlace
• NGSO MaRuC
• RTOG0724

Rare Tumour Committee

• Agenda
• ANEMONE
• Clear Cell XRT
• ENGOT
• Ovarian Serous Carinoma
• GINECO Aleinor
• KGOG Germ Cell
• mEOC
• Rare Tumor Task Force
• ATARI/NCRI
• REDCap

Endometrial Cancer Committee Presentations: Vienna 2017

• Agenda
• BGOG EN5
• DGOG  PORTEC 4a
• DGOG PORTEC 3
• GCIG EN Debate
• MaNGO AtTEnd
• NRG GOG_closed_ongoing
• NRG GOG_new
• MITO_AGO AdvEN
• Mariani-Greggi
• MITO_ECCo
• NCRI STATEC
• NSGO EN2
• NSGO FANDANGO
• NSGO PALEO

Phase II Committee

• Agenda
• NSGO Phase 2

Meta-Analysis Working Group

• Agenda

Education Working Group

• Agenda

Ovarian Cancer Committee

• Agenda
• AGO Desktop
• AGO LION closed
• AGO Penelope
• AGO TRUST
• AGO-OVAR 17
• AGO-OVAR2.21
• ANITA
• ENGOT PRIMA
• ICON8_ICON8B
• ICON9
• MaNGO INOVATYON
• MITO 16B
• MITO slides
• GINECO Atalante
• GINECO EWOC
• GINECO FIRST Trial
• GINECO OREO
• GINECO PAOLA
• GINECO SOLO2
• NSGO AVANOVA
• NSGO NOVA
• NSGO OV30 UMBRELLA
• NSGO OV42 AVANOVA-Immune1
• SGOG NACT
• NRG GY004
• GOG 3015
• NRG NACT
• NRG OV1719

Translational Research Committee

• Agenda

Quality Assurance Brainstorming

Educational Symposium

• Bookman Slides GCIG_Symposium
• Berger Slides GCIG_Symposium
• Fujiwara Slides GCIG_Symposium
• Berek Slides - Where Should You Publish - GCIG_Symposium
• Berek Slides -Why Create a National Group - GCIG_Symposium
• Sehouli Slides GCIG_Symposium
• Oaknin Slides GCIG_Symposium
• Marth Slides GCIG_Symposium
• Chavez Slides GCIG_Symposium
• Pujade-Lauraine Slides GCIG_Symposium
• Bryce Slides GCIG_Symposium
• Embleton Slides GCIG_Symposium
• Poveda Slides - Closing Remarks - GCIG_Symposium

The presenter retains all rights to slides created by the presenter and posted here.

We are pleased to inform you that we have contracted a reduced room rate at the Hotel Regina for attendees to GCIG in Vienna in November.For those wishing to make bookings early, the link information is below.The hotel link for the Hotel Regina is: https://goo.gl/s06kKm with a special GCIG group rate of € 120/150. Location: Van-Swieten-Gasse 3, Wien, AustriaMap of meeting venue is here.

• Invitation Letter
• QA Brainstorming Registration
• Final Schedule (with Rooms)
• Final Satellite Schedule
• General Assembly Agenda
• Education Working Group Agenda
• Symptom Benefit Committee Agenda
• Phase II Committee Agenda
• Rare Tumours Committee Agenda
• CCRN Agenda
• Endometrial Cancer Committee Agenda
• Ovarian Cancer Committee Agenda
• Cervical Cancer Committee Agenda
• Meta-Analysis Working Group Agenda
• Translational Research Committee Agenda
• Harmonization Ops/Joint Committee Agenda

Dinner on Nov. 2 is at the Wiener Rathauskeller.  Google Map is here. 

2017 June GA Minutes
Presentations for the General Assembly :

• Translational Research Committee Report to the General Assembly
• Cervix Cancer Committee Report to the General Assembly
• Endometrial Cancer Committee Report to the General Assembly
• Ovarian Cancer Committee Report to the General Assembly
• Meta-Analysis Working Group Report to the General Assembly
• Finance Working Group Report to the General Assembly
• Harmonization Committee Operations Report to the General Assembly
• Phase II Report to the General Assembly
• Quality Assurance(QA) Working Group Report to the General Assembly
• Rare Tumour Committee Report to the General Assembly
• Symptom Benefit Committee Report to the General Assembly
• Gynecologic Cancer InterGroup Report

Presentations from the GCIG 2017 meeting in Chicago by the Endometrial Cancer Committee:

• Endometrial Cancer Committee Agenda
• Report to the General Assembly
• Ongoing Trial-Portec 4a
• MITO-AGO Slides
• Closed Trial-MaNGO
• Ongoing Trials-E.C.C.O.
• Ongoing Trials-ELCAT-AGO
• En Comm Slides
• New Trial Proposals
• Ongoing Trial-EN2-Merza
• Ongoing Trial-FANDANGO-Merza
• Ongoing Trial-PALEO-Merza
• Fleming Slides
• GOG NRG Corpus Report
• Seckl Slides
• Lu Debate Slides
• Ongoing Trial-NiCCC
• Activating Trial-STATEC
• TOTEM Trial Slides
• Ongoing Trial-TSR-042
• Ongoing Trial-EORTC

Presentations from the GCIG 2017 meeting in Chicago by the Cervix Cancer Committee:

• Cervix Cancer Committee Agenda
• Report to the General Assembly
• Casado Trial Slides
• SENTICOL Trial Slides
• G-COG Ongoing Trial Slides
• INTERLACE Trial Slides
• Mileshkin Trial Slides
• RAIDS CCRN Slides
• Plante Trial Slides

Presentations from the GCIG 2017 meeting in Chicago by the Ovarian Cancer Committee:

• Ovarian Cancer Committee Agenda
• Report to the General Assembly
• OV24 Slides
• JGOG3020 Slides
• SOLO-2 Slides
• PAOLA Slides
• ATALANTE Slides
• GOG-Bookman Slides
• GOTIC Closed Trials
• INOVATYON MaNGO Slides
• UMBRELLA Slides
• MITO Slides
• NCRI ICON8&ICON8B Slides
• NCRI ICON9 Slides
• NSGO CC1 MaRuC Slides
• OReO Slides
• SGCTG NiCCC Glasspool Slides
• TRUST and AGO Slides

Presentations from the GCIG 2017 meeting in Chicago by the Translational Research Committee:

• Translational Research Committee Agenda
• Report to the General Assembly
• Lheureux Trial Slides
• Speiser Trial Slides
• RAIDS Trial Slides
• Gourley Slides

Presentations from the GCIG 2017 meeting in Chicago by the Meta-Analysis Working Group:

• Meta-Analysis Working Group Agenda
• Report to the General Assembly
• Prognostic Values Slides
• Surrogacy Ovarian Status Slides
• Paul Slides

Presentations from the GCIG 2017 meeting in Chicago by the Finance Working Group:

• Report to the General Assembly
• Terms of Reference
• GCIG Finance Expenditures Guidelines

Presentations from the GCIG 2017 meeting in Chicago by the Harmonization Committee Operations:

• Harmonization Committee Operations Agenda
• Report to the General Assembly
• Insurance and Indemnity Slides
• Checklist for a GCIG Clinical Trial Budget
• Harmonization-Ops Joint Minutes

Presentations from the GCIG 2017 meeting in Chicago by the Phase II Committee:

• Phase II Committee Agenda
• Report to the General Assembly
• NSGO FANDANGO
• G-TAC Slides
• UMBRELLA Slides
• NSGO-CC1-MaRuC
• CCTG STICs and STONES

Presentations from the GCIG 2017 meeting in Chicago by the Quality Assurance(QA) Working Group:

• Quality Assurance Working Group Agenda
• Report to the General Assembly
• Good Clinical Practice Slides

Presentations from the GCIG 2017 meeting in Chicago by the Rare Turmours Committee:

• Rare Turmours Committee Agenda
• Report to the General Assembly
• Minutes
• Gershenson LGSC CP Letrozole Slides
• ALIENOR Slides
• EORTC Slides
• GTD Seckl Slides
• NiCCC Slides
• ENGOT Slides
• REDCap Database Slides
• Clear Cell Slides

Presentations from the GCIG 2017 meeting in Chicago by the Symptom Benefit Committee:

• Symptom Benefit Committee Agenda
• Report to the General Assembly
• 5^thOCCC Trials
• AURELIA QOL Slides
• OVAR 16 QOL Slides
• Symptom Beneift Update Slides
• GOG-273 Slides
• PRO CTCAEs Slides
• Expression VII Slides
• TRIAS Slides

Presentations from the GCIG 2017 meeting in Chicago by the Cervix Cancer Research Network (CCRN):

• CCRN Agenda
• RAIDS OCCRN Slides
• SHAPE Slides
• Ongoing Trials
• INTERLACE Slides
• Jhingran Slides
• OUTBACK Slides
• SENTICOL III Slides

Presentations from the GCIG 2017 meeting in Chicago by the Education Working Group:

• Agenda
• Report to the General Assembly
• JSB Gynecologic Cancer Education Advisory Task Force Minutes